ArticleCancer management and research2020

Inhibition of Skp2 Sensitizes Chronic Myeloid Leukemia Cells to Imatinib.

Xiaowen Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.